CORC  > 复旦大学上海医学院
Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial.
Han, Guohong; Yang, Jijin; Shao, Guoliang; Teng, Gaojun; Wang, Maoqiang; Yang, Jianyong; Liu, Zhaoyu; Feng, Gansheng; Yang, Renjie; Lu, Ligong
2012
卷号30
期号15
会议录JOURNAL OF CLINICAL ONCOLOGY
语种英语
URL标识查看原文
ISSN号0732-183X
内容类型会议论文
URI标识http://www.corc.org.cn/handle/1471x/4910065
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Han, Guohong,Yang, Jijin,Shao, Guoliang,et al. Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial.[C]. 见:.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace